Team members Team members

Team Bio


Advisory Board

Dr. Atman Pai’s career began as a Howard Hughes Medical Institute Research Scholar in Michael Gottesman’s cell biology laboratory at the National Institutes of Health in 2000. This evolved into a focus in the radiation oncology sciences; his radiobiology training began in 2003, in the laboratories of James Mitchell and Kevin Camphausen of the National Cancer Institute, where he developed a phase II study of an adult high grade glioma radiosensitizer.

In 2007, he moved to St. Jude Children’s Research Hospital, where he focused on pediatric cancer and design of institutional and Children’s Oncology Group clinical trials. He authored protocols with primary focus on brain tumors, rhabdomyosarcoma and neuroblastoma. He continues to serve on national study group committees related to frontline clinical protocol development. While there, he conducted radiosensitization studies of multiple pediatric cancer histiotypes in an immunobiology laboratory, which are ongoing today.

With years of intensity modulated proton therapy (IMPT) experience at multiple high volume clinics, his current position combines pencil-beam proton radiobiology with clinical research at proton therapy centers around the globe. His goal is to develop novel pediatric studies employing safe, effective delivery of IMPT with molecularly targeted agents.

Dr. Pai was one of the doctors that treated Bryce Newman during his fight with brain cancer. Bryce always felt most comfortable in Dr. Pai’s care because of his demeanor and care for all the patients he treated. Dr. Pai even used his military training to repel down the Hyatt Manchester Hotel in San Diego along with Bryce. The event was to raise awareness and funding for trials in Pediatric Brain Cancer.

Dr. Pai is a native Texan and avid cyclist. His young daughters are also learning to follow in their father’s bike trails. His devotion to children suffering from cancer is unparalleled, and our Foundation is blessed to have him on our Advisory Board.

Helping enrich the lives of children suffering from pediatric cancer.